• Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years Cite CITE Title : Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118588 Oliver, Sara E. (2022). Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years. 202208(80606). Oliver, Sara E. "Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years" 202208, no. 80606 (2022) Oliver, Sara E. "Evidence to Recommendation Framework : Moderna COVID-19 vaccine in children ages 6 – 11 years and adolescents ages 12 – 17 years" vol. 202208, no. 80606, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 7.14 MB] Personal Author: Oliver, Sara E. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: /06-COVID-Oliver-508.pdf File Type: [PDF - 7.14 MB] File Type: [PDF - 7.14 MB] Update on myocarditis following mRNA COVID-19 vaccination Cite CITE Title : Update on myocarditis following mRNA COVID-19 vaccination Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Coordination Unit. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118585 Shimabukuro, Tom T. (2022). Update on myocarditis following mRNA COVID-19 vaccination. 202208(80603). Shimabukuro, Tom T. "Update on myocarditis following mRNA COVID-19 vaccination" 202208, no. 80603 (2022) Shimabukuro, Tom T. "Update on myocarditis following mRNA COVID-19 vaccination" vol. 202208, no. 80603, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 2.10 MB] Personal Author: Shimabukuro, Tom T. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 03-COVID-Shimabukuro-508.pdf File Type: [PDF - 2.10 MB] File Type: [PDF - 2.10 MB] Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2 Cite CITE Title : Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2 Personal Author(s) : Saydah, Sharon Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118584 Saydah, Sharon (2022). Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2. 202208(80602). Saydah, Sharon "Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2" 202208, no. 80602 (2022) Saydah, Sharon "Burden, prevalence, and trends of long-term sequelae of SARS-CoV-2" vol. 202208, no. 80602, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 2.00 MB] Personal Author: Saydah, Sharon June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 02-COVID-Briggs-Hagan-508.pdf File Type: [PDF - 2.00 MB] File Type: [PDF - 2.00 MB] Epidemiology and burden of respiratory syncytial virus in older adults in the U.S. Cite CITE Title : Epidemiology and burden of respiratory syncytial virus in older adults in the U.S. Personal Author(s) : Havers, Fiona Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Respiratory Viruses Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118594 Havers, Fiona (2022). Epidemiology and burden of respiratory syncytial virus in older adults in the U.S.. 202208(80804). Havers, Fiona "Epidemiology and burden of respiratory syncytial virus in older adults in the U.S." 202208, no. 80804 (2022) Havers, Fiona "Epidemiology and burden of respiratory syncytial virus in older adults in the U.S." vol. 202208, no. 80804, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.90 MB] Personal Author: Havers, Fiona June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: 04-RSV-Havers-508.pdf File Type: [PDF - 1.90 MB] File Type: [PDF - 1.90 MB] COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment Cite CITE Title : COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment Personal Author(s) : Talbot, H. Keipp;Hopkins, Robert H.; Corporate Authors(s) : COVID-19 Vaccine Safety Technical (VaST) Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118586 Talbot, H. Keipp and Hopkins, Robert H. (2022). COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment. 202208(80604). Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment" 202208, no. 80604 (2022) Talbot, H. Keipp and Hopkins, Robert H. "COVID-19 Vaccine Safety Technical (VaST) Work Group : VaST assessment" vol. 202208, no. 80604, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 437.60 KB] Personal Author: Talbot, H. Keipp ; Hopkins, Robert H. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 04-COVID-Talbot-508.pdf File Type: [PDF - 437.60 KB] File Type: [PDF - 437.60 KB] Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17 Cite CITE Title : Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17 Personal Author(s) : Hall, Elisha Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118589 Hall, Elisha (2022). Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17. 202208(80607). Hall, Elisha "Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17" 202208, no. 80607 (2022) Hall, Elisha "Interim clinical considerations update : Moderna COVID-19 vaccine for children ages 6−17" vol. 202208, no. 80607, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 3.14 MB] Personal Author: Hall, Elisha June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 07-COVID-Hall-508.pdf File Type: [PDF - 3.14 MB] File Type: [PDF - 3.14 MB] ACIP COVID-19 Vaccines Work Group : June 23, 2022 Cite CITE Title : ACIP COVID-19 Vaccines Work Group : June 23, 2022 Personal Author(s) : Daley, Matthew F. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118583 Daley, Matthew F. (2022). ACIP COVID-19 Vaccines Work Group : June 23, 2022. 202208(80601). Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group : June 23, 2022" 202208, no. 80601 (2022) Daley, Matthew F. "ACIP COVID-19 Vaccines Work Group : June 23, 2022" vol. 202208, no. 80601, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.75 MB] Personal Author: Daley, Matthew F. June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 01-COVID-Daley-508.pdf File Type: [PDF - 1.75 MB] File Type: [PDF - 1.75 MB] Influenza Work Group : introduction Cite CITE Title : Influenza Work Group : introduction Personal Author(s) : Talbot, H. Keipp Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Influenza Work Group;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/118568 Talbot, H. Keipp (2022). Influenza Work Group : introduction. 202208(80101). Talbot, H. Keipp "Influenza Work Group : introduction" 202208, no. 80101 (2022) Talbot, H. Keipp "Influenza Work Group : introduction" vol. 202208, no. 80101, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 121.24 KB] Personal Author: Talbot, H. Keipp June 22, 2022 | ACIP meeting Influenza Description: 01-influenza-talbot-508.pdf File Type: [PDF - 121.24 KB] File Type: [PDF - 121.24 KB] Nirsevimab for the prevention of RSV disease in all infants Cite CITE Title : Nirsevimab for the prevention of RSV disease in all infants Personal Author(s) : Felter, C. Corporate Authors(s) : Sanofi AstraZeneca Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118595 Felter, C. (2022). Nirsevimab for the prevention of RSV disease in all infants. 202208(80805). Felter, C. "Nirsevimab for the prevention of RSV disease in all infants" 202208, no. 80805 (2022) Felter, C. "Nirsevimab for the prevention of RSV disease in all infants" vol. 202208, no. 80805, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.43 MB] Personal Author: Felter, C. June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: slides-2022-06-22-23/05-RSV-Felter-508.pdf File Type: [PDF - 1.43 MB] File Type: [PDF - 1.43 MB] Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children Cite CITE Title : Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children Personal Author(s) : McMorrow, Meredith Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Respiratory Viruses Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118593 McMorrow, Meredith (2022). Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children. 202208(80803). McMorrow, Meredith "Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children" 202208, no. 80803 (2022) McMorrow, Meredith "Respiratory Syncytial Virus (RSV) seasonality in the United States and the burden of RSV in children" vol. 202208, no. 80803, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 888.17 KB] Personal Author: McMorrow, Meredith June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: 03-RSV-McMorrow-508.pdf File Type: [PDF - 888.17 KB] File Type: [PDF - 888.17 KB] Monkeypox update Cite CITE Title : Monkeypox update Personal Author(s) : Petersen, Brett W. Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Monkeypox informational session URL : https://stacks.cdc.gov/view/cdc/118598 Petersen, Brett W. (2022). Monkeypox update. 202208(81002). Petersen, Brett W. "Monkeypox update" 202208, no. 81002 (2022) Petersen, Brett W. "Monkeypox update" vol. 202208, no. 81002, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 691.02 KB] Personal Author: Petersen, Brett W. June 23, 2022 | ACIP meeting Monkeypox informational session Description: 02-MPX-Petersen-508.pdf File Type: [PDF - 691.02 KB] File Type: [PDF - 691.02 KB] Situational awareness : Monkeypox outbreak—United States, June 2022 Cite CITE Title : Situational awareness : Monkeypox outbreak—United States, June 2022 Personal Author(s) : Rao, Agam Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Monkeypox informational session URL : https://stacks.cdc.gov/view/cdc/118597 Rao, Agam (2022). Situational awareness : Monkeypox outbreak—United States, June 2022. 202208(81001). Rao, Agam "Situational awareness : Monkeypox outbreak—United States, June 2022" 202208, no. 81001 (2022) Rao, Agam "Situational awareness : Monkeypox outbreak—United States, June 2022" vol. 202208, no. 81001, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.86 MB] Personal Author: Rao, Agam June 23, 2022 | ACIP meeting Monkeypox informational session Description: 01-OPX-Rao-508.pdf File Type: [PDF - 1.86 MB] File Type: [PDF - 1.86 MB] RSV virion and vaccine products Cite CITE Title : RSV virion and vaccine products Personal Author(s) : Thornburg, Natalie J. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine URL : https://stacks.cdc.gov/view/cdc/118592 Thornburg, Natalie J. (2022). RSV virion and vaccine products. 202208(80802). Thornburg, Natalie J. "RSV virion and vaccine products" 202208, no. 80802 (2022) Thornburg, Natalie J. "RSV virion and vaccine products" vol. 202208, no. 80802, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 4.35 MB] Personal Author: Thornburg, Natalie J. June 23, 2022 | ACIP meeting Respiratory Syncytial Virus (RSV) Vaccine Description: 02-RSV-Thornburg-508.pdf File Type: [PDF - 4.35 MB] File Type: [PDF - 4.35 MB] Priorix for prevention of Measles, Mumps, and Rubella Cite CITE Title : Priorix for prevention of Measles, Mumps, and Rubella Personal Author(s) : Krow-Lucal, Elisabeth R. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Measles, Mumps, and Rubella (MMR) Vaccine Work Group.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Mumps URL : https://stacks.cdc.gov/view/cdc/118578 Krow-Lucal, Elisabeth R. (2022). Priorix for prevention of Measles, Mumps, and Rubella. 202208(80402). Krow-Lucal, Elisabeth R. "Priorix for prevention of Measles, Mumps, and Rubella" 202208, no. 80402 (2022) Krow-Lucal, Elisabeth R. "Priorix for prevention of Measles, Mumps, and Rubella" vol. 202208, no. 80402, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 812.56 KB] Personal Author: Krow-Lucal, Elisabeth R. June 22, 2022 | ACIP meeting Mumps Description: 02-MMR-Krow-Lucal-508.pdf File Type: [PDF - 812.56 KB] File Type: [PDF - 812.56 KB] One-dose human papillomavirus (HPV) vaccination : overview of current evidence Cite CITE Title : One-dose human papillomavirus (HPV) vaccination : overview of current evidence Personal Author(s) : Markowitz, Lauri E. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Human Papillomavirus (HPV) Vaccines Update URL : https://stacks.cdc.gov/view/cdc/118582 Markowitz, Lauri E. (2022). One-dose human papillomavirus (HPV) vaccination : overview of current evidence. 202208(80504). Markowitz, Lauri E. "One-dose human papillomavirus (HPV) vaccination : overview of current evidence" 202208, no. 80504 (2022) Markowitz, Lauri E. "One-dose human papillomavirus (HPV) vaccination : overview of current evidence" vol. 202208, no. 80504, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.02 MB] Personal Author: Markowitz, Lauri E. June 22, 2022 | ACIP meeting Human Papillomavirus (HPV) Vaccines Update Description: 04-HPV-Markowitz-508.pdf File Type: [PDF - 1.02 MB] File Type: [PDF - 1.02 MB] mRNA-1273 (Moderna COVID-19 vaccine) in individuals 6 - 17 years of age Cite CITE Title : mRNA-1273 (Moderna COVID-19 vaccine) in individuals 6 - 17 years of age Personal Author(s) : Das, Rituparna Corporate Authors(s) : Moderna TX, Inc. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 23, 2022 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/118587 Das, Rituparna (2022). mRNA-1273 (Moderna COVID-19 vaccine) in individuals 6 - 17 years of age. 202208(80605). Das, Rituparna "mRNA-1273 (Moderna COVID-19 vaccine) in individuals 6 - 17 years of age" 202208, no. 80605 (2022) Das, Rituparna "mRNA-1273 (Moderna COVID-19 vaccine) in individuals 6 - 17 years of age" vol. 202208, no. 80605, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.57 MB] Personal Author: Das, Rituparna June 23, 2022 | ACIP meeting COVID-19 Vaccines Description: 05-COVID-Das-508.pdf File Type: [PDF - 1.57 MB] File Type: [PDF - 1.57 MB] Impact of the US HPV vaccination program on HPV-associated outcomes Cite CITE Title : Impact of the US HPV vaccination program on HPV-associated outcomes Personal Author(s) : Gargano, Julia W. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Human Papillomavirus (HPV) Vaccines Update URL : https://stacks.cdc.gov/view/cdc/118581 Gargano, Julia W. (2022). Impact of the US HPV vaccination program on HPV-associated outcomes. 202208(80503). Gargano, Julia W. "Impact of the US HPV vaccination program on HPV-associated outcomes" 202208, no. 80503 (2022) Gargano, Julia W. "Impact of the US HPV vaccination program on HPV-associated outcomes" vol. 202208, no. 80503, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 669.73 KB] Personal Author: Gargano, Julia W. June 22, 2022 | ACIP meeting Human Papillomavirus (HPV) Vaccines Update Description: 03-HPV-Gargano-508.pdf File Type: [PDF - 669.73 KB] File Type: [PDF - 669.73 KB] National and state-level HPV vaccination coverage Cite CITE Title : National and state-level HPV vaccination coverage Personal Author(s) : Stokley, Shannon Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Human Papillomavirus (HPV) Vaccines Update URL : https://stacks.cdc.gov/view/cdc/118580 Stokley, Shannon (2022). National and state-level HPV vaccination coverage. 202208(80502). Stokley, Shannon "National and state-level HPV vaccination coverage" 202208, no. 80502 (2022) Stokley, Shannon "National and state-level HPV vaccination coverage" vol. 202208, no. 80502, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 783.99 KB] Personal Author: Stokley, Shannon June 22, 2022 | ACIP meeting Human Papillomavirus (HPV) Vaccines Update Description: 02-HPV-Stokley-508.pdf File Type: [PDF - 783.99 KB] File Type: [PDF - 783.99 KB] Clinical considerations for use of PCV15 in children Cite CITE Title : Clinical considerations for use of PCV15 in children Personal Author(s) : Kobayashi, Miwako Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/118576 Kobayashi, Miwako (2022). Clinical considerations for use of PCV15 in children. 202208(80205). Kobayashi, Miwako "Clinical considerations for use of PCV15 in children" 202208, no. 80205 (2022) Kobayashi, Miwako "Clinical considerations for use of PCV15 in children" vol. 202208, no. 80205, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 242.91 KB] Personal Author: Kobayashi, Miwako June 22, 2022 | ACIP meeting Pneumococcal Vaccines Description: 05-Pneumococcal-Kobayashi-508.pdf File Type: [PDF - 242.91 KB] File Type: [PDF - 242.91 KB] Pneumococcal vaccines Cite CITE Title : Pneumococcal vaccines Personal Author(s) : Poehling, Katherine A. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group.;National Center for Immunization and Respiratory Diseases (U.S.); Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2022 June 22 : Atlanta, GA) Published Date : June 22, 2022 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/118572 Poehling, Katherine A. (2022). Pneumococcal vaccines. 202208(80201). Poehling, Katherine A. "Pneumococcal vaccines" 202208, no. 80201 (2022) Poehling, Katherine A. "Pneumococcal vaccines" vol. 202208, no. 80201, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 129.05 KB] Personal Author: Poehling, Katherine A. June 22, 2022 | ACIP meeting Pneumococcal Vaccines Description: 01-Pneumococcal-Poehling-508.pdf File Type: [PDF - 129.05 KB] File Type: [PDF - 129.05 KB]

More +